Target intelligence / Profile preview

BRICK1 pseudogene 1 (BRK1P1)

Target
BRK1P1
Molecular classification
Other (Pseudogene)
01

Overview

BRICK1 pseudogene 1 (BRK1P1) is a processed pseudogene in the human genome. Pseudogenes arise from coding genes through mutation, duplication, or retrotransposition events, most often resulting in a locus unable to code for a functional protein. While some pseudogenes can regulate gene expression by competing for shared microRNAs or interacting with RNA-binding proteins, most have no known biological function. BRK1P1 is not known to encode a functional protein, is not a recognized therapeutic target, and currently has no established clinical or disease associations. The presence of "pseudogene" in the name and the "P" in the abbreviation indicate this is not an active protein-coding gene but an inactive or non-functional remnant. There is no evidence that BRICK1 pseudogene 1 has therapeutic relevance or interacts with drugs, nor is it established as a biomarker or safety concern. These features make it an incorrect choice as a canonical drug target. If you need information on a functionally relevant BRICK1 protein or canonical drug target, clarification is required.

Other names
BRK1P1
02

Biological functions

Pseudogenes are generally considered nonfunctional due to disabling mutations, but some may regulate their parental gene or participate in competitive endogenous RNA (ceRNA) networksCompete for microRNA binding, indirectly regulating gene expressionInteract with RNA-binding proteins impacting mRNA stability of related genes
03

Disease associations

Pseudogenes have been implicated in cancer and other diseases through regulatory functions, but there is no evidence for disease relevance of BRICK1 pseudogene 1 specifically

Beyond the preview

Go deeper on BRICK1 pseudogene 1 (BRK1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BRICK1 pseudogene 1 (BRK1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call